Mitsubishi Tanabe Pharma issues its news to provide stakeholders with the latest information related to the Company. Information on products or drug candidates may be included, but is intended to provide for the media, etc. It is not intended for promotion, advertising or medical advice.
Information Overseas Consolidated Subsidiary, Medicago to Cease Operations
February 3, 2023
The parent company of Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka, Japan; Representative Director: Hiroaki Ueno), Mitsubishi Chemical Group Corporation (Head office: Chiyoda-ku, Tokyo; President: Jean-Marc Gilson) made the following announcement today.
Overseas Consolidated Subsidiary, Medicago to Cease Operations
URL: https://www.mcgc.com/english/news_release/pdf/01468/01708.pdf
Contact: mcgmedia@gcicanada.com